首页> 外国专利> Evaluation of anti infectious drugs and vaccines using immortalized monocyte and derived cells

Evaluation of anti infectious drugs and vaccines using immortalized monocyte and derived cells

机译:使用永生化单核细胞和衍生细胞的抗传染性药物和疫苗的评价

摘要

The present invention is based on the problem of stability, reproducibility, economics and ease of operation in monocyte or dendritic cell mediated infectious microbiology research. The aim of this study is to provide a method for maintaining and maintaining monocytes or dendritic cell mediated infectious microorganisms using monocytes having proliferative potential.The present invention is capable of proliferating human monocyte cells obtained by introducing genes into CD14 positive cells and cells having phagocytic abilities obtained by differentiating or inducing the monocyte cells It is based on the fact that dengue virus can efficiently infect and proliferate dendritic cells.This method provides a new method for the evaluation of pharmaceuticals such as compounds and vaccines for the treatment of infected bacterial infections with monocyte or dendritic cells.
机译:本发明基于单核细胞或树突细胞介导的传染性微生物学研究中稳定性,再现性,经济学和易于操作的问题。 本研究的目的是提供一种使用具有增殖潜力的单核细胞维持和维持单核细胞或树突细胞介导的传染性微生物的方法。本发明能够通过将基因引入CD14阳性细胞和具有吞噬能力的细胞来增殖获得的人单核细胞细胞 通过区分或诱导单核细胞细胞获得的是,即登革热病毒可以有效地感染和增殖树突细胞。该方法提供了评估药物等化合物和疫苗的新方法,用于治疗具有单核细胞的受感染的细菌感染 或树突细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号